LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $212,000 | -64.4% | 53,943 | -20.3% | 0.01% | -57.1% |
| Q3 2019 | $596,000 | +40.6% | 67,682 | +47.8% | 0.01% | +55.6% |
| Q2 2019 | $424,000 | +196.5% | 45,802 | +201.9% | 0.01% | +125.0% |
| Q4 2018 | $143,000 | -77.9% | 15,173 | -62.4% | 0.00% | -81.0% |
| Q2 2016 | $646,000 | -56.8% | 40,385 | -43.6% | 0.02% | -51.2% |
| Q1 2016 | $1,496,000 | – | 71,547 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 240,000 | $1,018,000 | 94.79% |
| TANG CAPITAL MANAGEMENT LLC | 9,405,490 | $39,879,000 | 11.22% |
| RTW INVESTMENTS, LP | 2,327,903 | $9,870,000 | 0.15% |
| Boxer Capital, LLC | 890,700 | $3,777,000 | 0.13% |
| FIRST MIDWEST BANK TRUST DIVISION | 89,341 | $379,000 | 0.05% |
| WealthTrust Axiom LLC | 30,400 | $128,000 | 0.04% |
| PREMIER ASSET MANAGEMENT LLC | 51,305 | $217,000 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 18,113 | $77,000 | 0.02% |
| HOLLENCREST CAPITAL MANAGEMENT | 39,000 | $165,000 | 0.02% |
| Inscription Capital, LLC | 10,000 | $42,000 | 0.01% |